Abstract:Background: MicroRNA-106b (miR-106b) is thought to be an oncogenic microRNA that promotes tumor growth and metastasis. The potential predictive value of miR-106b was studied in colonic cancer patients. Methods: The expression of miR-106b was examined in 180 colonic cancer cases using in situ hybridization (ISH) technique and was evaluated semi-quantitatively by examining the staining index. The Correlation of miR-106b expression and clinic-pathological features was analyzed by Spearman Rank Correlation. Wilcoxon signed rank test was used for assessing the expression difference of miRNA-106b between colonic cancerous and para-cancerous ones, and their effects on patient survival were analyzed by a log-rank test and the Kaplan-Meier method. Results: MiR-106b was higher expressed in para-cancerous tissues, compared with colonic cancerous ones (P < 0.001). A positive correlation of miR-106b levels between colonic and para-cancerous tissues was also observed (CC = 0.523, P < 0.001). Furthermore, the expression of miR-106b was not significantly correlated with clinic-pathological parameters, including gender, age, histological grade, tumor size, pT stage, pN stage, pM stage and pTNM stage of the patients. Histological grade was positively correlated with pT stage (P = 0.011), pN stage (P = 0.036) and pTNM stage (P = 0.009). Patients expressing high levels of miR-106b both in colonic cancer tissues and para-cancerous ones have a relatively longer survival time but the difference is not statistically significant (P = 0.16). Conclusions: The expression difference of miR-106b levels between colonic tissues and para-cancerous tissues is statistically significant, but the miR-106b levels were not quite correlated with clinic-pathological characteristics and overall survival times of patients with colonic cancer. Lower levels of miR-106b may be connected with neoplastic effects due to interference with TGF-beta signaling, providing evidence that down-regulation of miR-106b might also play an important role in the progression of the disease. The study results are consistent with the literature and support the notion that miR-106b is an oncogenic microRNA.

Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients.

Expression and significance of miR-654-5p and miR-376b-3p in patients with colon cancer

Downregulation of Mir-193A-5p Correlates with Lymph Node Metastasis and Poor Prognosis in Colorectal Cancer

Decreased expression of microRNA-192 correlates with tumor progression and poor prognosis in patients with colorectal cancer

The Deregulation of Mir-133B is Associated with Poor Prognosis in Bladder Cancer.

Clinical significance of microRNA-93 downregulation in human colon cancer.

Downregulation of Mir-138 Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.

Prognostic Value of Decreased Microrna-133A in Solid Cancers: a Meta-Analysis.

MicroRNA-206 Attenuates Tumor Proliferation and Migration Involving the Downregulation of NOTCH3 in Colorectal Cancer.

In Situ Hybridization Analysis of the Expression of Mir-106B in Colonic Cancer.

Downregulation of mir-23b in plasma is associated with poor prognosis in patients with colorectal cancer

Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior

Decreased Expression of Mir‑490‑3p in Colorectal Cancer Predicts Poor Prognosis and Promotes Cell Proliferation and Invasion by Targeting RAB14.

Upregulation of microRNA-196a and microRNA-196b cooperatively correlate with aggressive progression and unfavorable prognosis in patients with colorectal cancer

Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer

Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer

Low microRNA-217 expression in colorectal cancer tissues predicts poor prognosis in colorectal cancer patients

Up-regulation of microRNA-19b is associated with metastasis and predicts poor prognosis in patients with colorectal cancer

Downregulation of miR-654-3p in Colorectal Cancer Indicates Poor Prognosis and Promotes Cell Proliferation and Invasion by Targeting SRC

Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer.

MicroRNA‑133b inhibits connective tissue growth factor in colorectal cancer and correlates with the clinical stage of the disease.